UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 31, 2024 4:00 P.M.

Form:	S-3
CIK: 0001842952 Company Name: Context Therapeutics Inc. File Number: 333-279693